Medrad mobilizes MRI injector
Spectris has gone mobile. The injector of MRI contrast media has been adapted by Medrad for use in the tight quarters of MRI trailers. This configuration has a space-saving base-plate that secures the injector to the wall and a transportation clamp that
Spectris has gone mobile. The injector of MRI contrast media has been adapted by Medrad for use in the tight quarters of MRI trailers. This configuration has a space-saving base-plate that secures the injector to the wall and a transportation clamp that also secures the injector head to the wall for easy and safe transport. It is compatible with the four major mobile trailer manufacturers: Calumet Coach, Medical Coaches, AK Associates, and Ellis & Watts. The mobile configuration is currently available in North America and will roll out in Europe, Latin America, and Japan at a later date.
© 2001 Miller Freeman Inc.
3/28/01, Issue # 1506, page 6.
MRI Study at ARRS Raises Questions About Disparities in Detection of MASLD
May 3rd 2025New research revealed that Hispanic Americans with evidence of hepatic steatosis on MRI but no formal diagnosis of MASLD had over a fourfold higher risk of developing hepatocellular carcinoma in comparison to those who had a formal diagnosis of MASLD.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Contrast-Enhanced Mammography Study Reveals 24 Percent Lower Sensitivity with Moderate/Marked BPE
April 30th 2025In comparison to minimal or mild background parenchymal enhancement on contrast-enhanced mammography (CEM), researchers found that moderate or marked BPE was associated with a 12 percent lower AUC for breast cancer detection.
